4.6 Article

Rates and patterns of death after surgery in the United States, 1996 and 2006

期刊

SURGERY
卷 151, 期 2, 页码 171-182

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.surg.2011.07.021

关键词

-

类别

资金

  1. NIDDK NIH HHS [T32DK007754-11] Funding Source: Medline

向作者/读者索取更多资源

Background. Nationwide rates and patterns of death after surgey, are unknown. Methods. Using the Nationwide Inpatient Sample, we compared deaths within 30 days of admission for patients undergoing surgery in 1996 and 2006. International Classification of Diseases codes were used to identify 2,520 procedures for analysis. We examined the inpatient 30-day death rate for all procedures, procedures with the most deaths, high-risk cardiovascular and cancer procedures, and patients who suffered a recorded complication. We used logistic regression, modeling to adjust 1996 mortality rates to the age and gender distributions fir patients undergoing surgery in 2006. Results. In 1996, there were 12,573,331 admissions with a surgical procedure (95 % confidence interval [CI], 12,560,171-12,586,491) and 224,111 inpatient deaths within 30 days of admission (95% CI, 221,912-226,310). In 2006, there were 14,333,993 admissions with a surgical procedure (95% CI, 14, 320, 983-14, 347,002) and 189,690 deaths (95% CI, 187, 802-191, 578). inpatient 30-day mortality declined from 1.68% in 1996 to 1.32% in 2006 (P <.001). Of the 21 procedures with the most deaths in, 1996, 15 had significant declines in adjusted mortality in 2006. Among these 15 procedures, 8 had significant declines in operative volume. The inpatient 30-day mortality rate for patients who suffered a complication decreased from 12.10% to 9.84% (P <.001). Conclusion. Nationwide reporting on surgical mortality suggests that the number of inpatient deaths within 30 days of surgery has declined. Additional research to determine the underlying causes for decreased mortality is warranted. (Surgery 2012;151:171-82.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据